Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · IEX Real-Time Price · USD
70.68
+0.28 (0.40%)
Jul 26, 2024, 4:00 PM EDT - Market closed

PBH Revenue

In the fiscal year ending March 31, 2024, Prestige Consumer Healthcare had annual revenue of $1.13B, down -0.21%. Prestige Consumer Healthcare had revenue of $276.99M in the quarter ending March 31, 2024, a decrease of -3.11%.

Revenue (ttm)
$1.13B
Revenue Growth
-0.21%
P/S Ratio
3.12
Revenue / Employee
$2,009,566
Employees
560
Market Cap
3.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20241.13B-2.37M-0.21%
Mar 31, 20231.13B40.91M3.76%
Mar 31, 20221.09B143.45M15.21%
Mar 31, 2021943.37M-19.65M-2.04%
Mar 31, 2020963.01M-12.77M-1.31%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Axonics 387.14M
Denali Therapeutics 295.39M
Twist Bioscience 277.49M
Arcellx 131.66M
Alvotech 114.39M
Merus 38.34M
Arrowhead Pharmaceuticals 35.47M
IDEAYA Biosciences 15.50M
Revenue Rankings